Amgen (AMGN) Asset Utilization Ratio (2009 - 2026)
Amgen (AMGN) posted quarterly Asset Utilization Ratio of 0.41 for Q1 2026, up 7.94% year-over-year from 0.38 in Q1 2025, and little changed quarter-over-quarter from 0.41 in Q4 2025.
Amgen (AMGN) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Amgen's Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.41 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 7.94% year-over-year to 0.41; the TTM figure through Mar 2026 stood at 0.41 (up 7.94% YoY), while the FY2025 annual figure was 0.4, up 13.91% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.41, roughly flat from 0.41 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.45 in Q2 2022, with the low at 0.23 in Q2 2023.
- The 5-year median for Asset Utilization Ratio is 0.37 (2024), against an average of 0.35.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio sank 49.31% in 2023, then soared 58.2% in 2024.
- Amgen's Asset Utilization Ratio stood at 0.31 in 2022, then retreated by 2.98% to 0.3 in 2023, then increased by 21.79% to 0.37 in 2024, then climbed by 11.17% to 0.41 in 2025, then dropped by 0.03% to 0.41 in 2026.
- Business Quant data shows AMGN's Asset Utilization Ratio at 0.41 in Q1 2026, 0.41 in Q4 2025, and 0.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.64 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.40 |
| Mar 31, 2026 | 0.41 |
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | 0.40 |
| Jun 30, 2025 | 0.39 |
| Mar 31, 2025 | 0.38 |
| Dec 31, 2024 | 0.37 |
| Sep 30, 2024 | 0.36 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.31 |
| Dec 31, 2023 | 0.30 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.23 |
| Mar 31, 2023 | 0.26 |
| Dec 31, 2022 | 0.31 |
| Sep 30, 2022 | 0.43 |
| Jun 30, 2022 | 0.45 |
| Mar 31, 2022 | 0.44 |
| Dec 31, 2021 | 0.41 |
| Sep 30, 2021 | 0.41 |